Amoxicillin 200 mg and clavulanic acid 28.5 mg : Antibiotic Formula for Pediatric Infections
CLAVAMOXY LS ORAL SUSPENSION is a broad-spectrum antibiotic formulation designed especially for children, combining amoxicillin 200 mg and clavulanic acid 28.5 mg. It effectively treats a wide range of bacterial infections by targeting and eliminating the root cause. This dual-action oral suspension is formulated to ensure better palatability and compliance among pediatric patients.
Amoxicillin, a penicillin-type antibiotic, is widely used for its potent bactericidal action. However, certain bacteria produce beta-lactamase enzymes that can resist amoxicillin alone. To overcome this, clavulanic acid is added—a beta-lactamase inhibitor that neutralizes the enzymes and enhances the efficacy of amoxicillin.
The combination in CLAVAMOXY LS ORAL SUSPENSION ensures broader coverage against resistant bacterial strains, making it a reliable option for treating common and recurring infections in children.
Key Features and Ingredients
Amoxicillin 200 mg
A potent antibiotic from the penicillin group that works by stopping the growth of bacteria. It is effective against infections like tonsillitis, bronchitis, pneumonia, and ear, nose, and throat infections.
Clavulanic Acid 28.5 mg
A beta-lactamase inhibitor that protects amoxicillin from degradation by resistant bacteria. This ensures that the antibiotic retains its strength and works effectively.
Child-Friendly Suspension Base
Pleasant taste and easy-to-swallow liquid formulation improve pediatric adherence and treatment outcomes.
How to Use CLAVAMOXY LS ORAL SUSPENSION
Dosage: As prescribed by a pediatrician, usually based on the child’s weight and infection severity.
Administration: Shake the bottle well before use. Use a dosing syringe or spoon for accurate measurement.
Frequency: Typically given every 8–12 hours with or without food.
Storage: Store in a cool, dry place. Refrigerate once reconstituted and use within the prescribed time.
Always follow your doctor’s instructions. Do not skip doses or stop the medicine early even if the child feels better.
Key Benefits of CLAVAMOXY LS ORAL SUSPENSION
Broad-Spectrum Action
The combination of amoxicillin 200 mg and clavulanic acid 28.5 mg offers a powerful shield against a wide range of bacteria, including those resistant to conventional antibiotics.Enhanced Efficacy Against Resistant Bacteria
Clavulanic acid inhibits beta-lactamase enzymes, allowing amoxicillin to work against otherwise resistant pathogens.Safe and Effective Pediatric Formulation
Specially designed for children, the suspension offers optimal dosing, taste, and ease of use.Rapid Relief from Symptoms
Provides fast and lasting relief from symptoms such as fever, sore throat, earache, and chest congestion caused by bacterial infections.Reduced Risk of Recurrence
By effectively eradicating the root bacterial cause, the suspension minimizes the chances of infection recurrence.
Conclusion
CLAVAMOXY LS ORAL SUSPENSION, containing amoxicillin 200 mg and clavulanic acid 28.5 mg, is a trusted and clinically proven treatment for pediatric bacterial infections. Its dual mechanism ensures enhanced bacterial eradication, even in cases of resistant infections.
With its child-friendly formulation, broad-spectrum effectiveness, and rapid results, CLAVAMOXY LS ORAL SUSPENSION stands out as a first-choice antibiotic therapy in pediatric care.
